ctrl K

Price Alert

Actinium Pharmaceuticals ... (ATNM)

AMEX: ATNM · Real-Time Price · USD

1.69

0.04 (2.42%)

At close: Aug 15, 2025, 3:59 PM

1.69

0.00%

After-hours: Aug 15, 2025, 05:56 PM EDT

Actinium Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	72.9M	76.68M	108.91M	77.83M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	324K	313K	302K	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	357K	226K	396K	442K
Total Current Assets	74.51M	78.26M	110.94M	79.75M
Property-Plant & Equipment	2.07M	2.87M	2.95M	639K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.39M	3.18M	3.25M	639K
Total Assets	76.9M	81.44M	114.19M	80.39M
Account Payables	7.57M	7.95M	10.13M	5.54M
Deferred Revenue	n/a	n/a	35M	998K
Short-Term Debt	580K	541K	498K	307K
Other Current Liabilities	-580K	-541K	-35.5M	-307K
Total Current Liabilities	8.15M	8.49M	10.63M	6.84M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	35.99M	36.57M	37.08M	3K
Total Liabilities	44.14M	45.07M	47.71M	6.84M
Total Debt	1.57M	2.11M	2.58M	310K
Common Stock	31K	28K	26K	22K
Retained Earnings	-375.83M	-337.58M	-288.76M	-255.75M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	32.76M	36.38M	66.48M	73.55M
Total Investments	324K	313K	302K	n/a